Pediatric lupus nephritis: Management update

doi:10.5527/wjn.v3.i2.16

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 3, Issue 2

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8986)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-2) series.

Item

Count

PDF

678

WORD

373

HTML

5361

Figures (1-2)

236

Tables (1-2)

206

Sum=6854

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1110

Download

1022

Sum=2132

May 6, 2014 (publication date) through Aug 31, 2024

Times Cited of This Article

Times Cited (32)

Journal Information of This Article

Publication Name

World Journal of Nephrology

ISSN

2220-6124

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Nephrol. May 6, 2014; 3(2): 16-23
Published online May 6, 2014. doi: 10.5527/wjn.v3.i2.16

Full Size Figure Download Figure

Figure 2 Treatment of class V without proliferative changes and with nephrotic range proteinuria (> 3 g/24 h). MMF: Mycophenolate mofetil; AZA: Azathioprine; CYC: Cyclophosphamide; GC: Glucocorticoids.

Citation: Sinha R, Raut S. Pediatric lupus nephritis: Management update. World J Nephrol 2014; 3(2): 16-23
URL: https://www.wjgnet.com/2220-6124/full/v3/i2/16.htm
DOI: https://dx.doi.org/10.5527/wjn.v3.i2.16